Soros Fund Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Soros Fund Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-60,000	Closed	-$3.15M	–	183
2020 Q3	$3.15M	Buy	+60,000	New	+$2.48M	0.08%	100

Soros Fund Management's MNTA Position: Q4 2020 in Review

Soros Fund Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 60,000 shares — an estimated $3.15M sold.

Soros Fund Management first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $3.15M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Soros Fund Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Soros Fund Management sold 60,000 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $3.15M.
Soros Fund Management first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
Soros Fund Management's Momenta Pharmaceuticals, Inc. position peaked at $3.15M in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Soros Fund Management's 13F filing for Q4 2020, filed 16 Feb 2021.